GO:0106341 omega-hydroxyceramide transacylase activity

Omega-hydroxyceramide transacylase activity (GO:0106341) is a molecular function that catalyzes the final step in the biosynthesis of omega-O-acylceramide, a critical lipid for the skin's permeability barrier. This activity transfers a linoleoyl group from a triacylglycerol to an omega-hydroxy-ultra-long-chain fatty acyl-sphingoid base, yielding omega-O-acylceramide and diacylglycerol. The reaction is essential for the formation of the corneocyte lipid envelope, which prevents water loss and protects against environmental insults. Researchers study GO:0106341 to understand skin barrier biology, lipid metabolism, and the pathogenesis of ichthyosis and other skin disorders. The enzyme responsible, PNPLA1, belongs to the patatin-like phospholipase domain-containing family, but it functions as a transacylase rather than a phospholipase in this context. Defects in PNPLA1 lead to abnormal lipid processing and compromised barrier function, highlighting the importance of this activity in human health. This article provides a comprehensive overview of the mechanism, key genes, regulatory aspects, disease associations, and experimental approaches for investigating omega-hydroxyceramide transacylase activity, with a focus on CRISPR-based models and modern analytical techniques.

In our own words, omega-hydroxyceramide transacylase activity (GO:0106341) is the catalytic function that moves a linoleoyl (9Z,12Z-octadecadienoyl) group from a triacylglycerol molecule onto an N-(omega-hydroxy-ultra-long chain fatty acyl)-sphingoid base. This reaction produces an N-[omega-(9Z,12Z-octadecadienoyloxy)-O-ultra-long chain fatty acyl]-sphingoid base, commonly known as omega-O-acylceramide, and releases a diacylglycerol as a byproduct.

Omega-hydroxyceramide transacylase activity is essential for the production of omega-O-acylceramide, a unique lipid that constitutes the corneocyte lipid envelope and is indispensable for the skin's water-impermeable barrier. Without this activity, the skin barrier is compromised, leading to excessive water loss and increased susceptibility to infections and irritants. This function is therefore central to dermatological research and to understanding congenital skin disorders such as autosomal recessive congenital ichthyosis.

The following genes and proteins are directly or indirectly involved in omega-hydroxyceramide transacylase activity and its biological context.

The regulation of omega-hydroxyceramide transacylase activity is not fully understood, but it likely involves transcriptional control of PNPLA1 and post-translational modifications, as well as availability of lipid substrates. PNPLA1 expression may be regulated by transcription factors involved in epidermal differentiation, such as PPARs and LXR, although direct evidence is limited. Additionally, the activity could be modulated by interactions with other proteins like ABHD5/CGI-58, which are known to regulate lipid metabolism enzymes. Further research is needed to elucidate the precise regulatory mechanisms.

Mutations in PNPLA1, the enzyme responsible for omega-hydroxyceramide transacylase activity, cause autosomal recessive congenital ichthyosis, a severe skin disorder characterized by defective skin barrier and abnormal desquamation. Loss of omega-O-acylceramide leads to impaired permeability barrier, resulting in excessive water loss and scaling.

Defects in omega-O-acylceramide synthesis can contribute to skin barrier dysfunction observed in atopic dermatitis and other inflammatory skin diseases, although direct mutations in PNPLA1 are primarily linked to ichthyosis. Reduced barrier function allows allergens and irritants to penetrate, exacerbating inflammation.

Given the role of PNPLA1 in lipid metabolism, alterations in its activity might influence systemic lipid homeostasis, but current evidence is mainly limited to skin phenotypes. Further studies are needed to explore potential links to metabolic syndromes.

Lipidomics using LC-MS/MS is essential to quantify omega-O-acylceramide and other lipids in cells and tissues, allowing assessment of transacylase activity. This method can detect changes in lipid profiles upon PNPLA1 knockout or overexpression.

In vitro assays with recombinant PNPLA1 and radiolabeled or fluorescent substrates can directly measure transacylase activity and determine kinetic parameters. Such assays help dissect the catalytic mechanism and substrate specificity.

CRISPR knockout, point mutation, and knock-in models enable precise manipulation of PNPLA1 and related genes to study their roles in omega-hydroxyceramide transacylase activity and skin barrier function.

Trans-epidermal water loss (TEWL) measurements and dye penetration assays in mouse models or 3D skin equivalents assess the functional consequences of altered transacylase activity.

Researchers studying omega-hydroxyceramide transacylase activity-related genes often need to determine whether a candidate gene is causally involved in lipid metabolism and skin barrier function. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell and animal models, enabling rigorous investigation of gene function and disease mechanisms.

Omega-hydroxyceramide transacylase activity (GO:0106341) is a specialized molecular function critical for skin barrier formation, primarily mediated by PNPLA1. Defects in this activity lead to severe skin disorders such as autosomal recessive congenital ichthyosis, underscoring its clinical importance. Understanding the mechanism, regulation, and disease links of this activity requires interdisciplinary approaches, including lipidomics, enzymology, and CRISPR-based genome editing. EDITGENE offers comprehensive CRISPR services to facilitate research on PNPLA1 and related genes, enabling the creation of knockout, point mutation, knock-in, and overexpression models. By leveraging these tools, researchers can accelerate discoveries in skin biology and develop potential therapies for barrier disorders.